| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |